Meitav Dash Investments LTD Eloxx Pharmaceuticals, Inc. Transaction History

Meitav Dash Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$1.96 - $7.96 $663,763 - $2.7 Million	-338,655 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$3.19 - $7.56 $137,294 - $325,374	-43,039 Reduced 11.28%	338,655 $2.49 Million
Q3 2019 Nov 14, 2019	SELL	$4.37 - $9.91 $518,902 - $1.18 Million	-118,742 Reduced 23.73%	381,694 $1.75 Million
Q1 2019 May 13, 2019	SELL	$10.45 - $13.94 $168,318 - $224,531	-16,107 Reduced 3.12%	500,436 $5.85 Million
Q4 2018 Feb 13, 2019	SELL	$10.43 - $17.39 $207,995 - $346,791	-19,942 Reduced 3.72%	516,543 $6.2 Million
Q2 2018 Aug 14, 2018	BUY	$8.75 - $23.27 $4.69 Million - $12.5 Million	536,485 New	536,485 $7.86 Million

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.